does retatrutide burn fat for weight loss: how it works & availability Retatrutide Subcutaneous Fat Loss Results:

We found that the rate of thyroid cancer was lower in the patients prescribed GLP-1 medications, but the decrease was only statistically significant in the patients with a BMI between 30 and 35, or class 1 obesity, as shown in Figure 2

On the contrary, for the same treatment period but at a drug concentration of 1.0 mg, there was only 1 case of thyroid cancer (Table 4)

You should not take a GLP-1 drug if you have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis or a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis

Nghin cu trn ng vt cho thy liraglutide gip thay i c tnh ca i thc bo, tng s phn gii mng x va v gim nguy c tc nghn mch mu